PPA
VTYX

Parametric Portfolio Associates’s Ventyx Biosciences VTYX Stock Holding History

Parametric Portfolio Associates’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,934
Closed -$217K – 3772
2021
Q4 		$217K Buy
+10,934
New +$207K ﹤0.01% 3395

Other funds holding VTYX

VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Parametric Portfolio Associates's VTYX Position: Q1 2022 in Review

Parametric Portfolio Associates sold out of Ventyx Biosciences (VTYX) in Q1 2022, closing a stake of 10,934 shares — an estimated $217K sold.

Parametric Portfolio Associates first reported a position in VTYX in Q4 2021 and held it in 1 quarter. The position peaked at $217K in Q4 2021. 55 funds tracked by Wall St. Rank hold VTYX as of Q1 2022.

  • Parametric Portfolio Associates reported no remaining Ventyx Biosciences position as of Q1 2022 after selling out during the quarter.
  • Parametric Portfolio Associates sold 10,934 Ventyx Biosciences shares in Q1 2022, an estimated $217K.
  • Parametric Portfolio Associates first reported a position in Ventyx Biosciences in Q4 2021 and held it in 1 quarter.
  • Parametric Portfolio Associates's Ventyx Biosciences position peaked at $217K in Q4 2021.
  • 55 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.